The Difficult Decisions to Make Based on the Macro Environment

Sorepta Therapeutics, which is just recently received conditional approval or accelerated approval for their gene therapy for Duchenne muscular dystrophy reported earnings on Wednesday night. And they at the same time simultaneously announced that they had the first patient infused with their gene therapy on a commercial basis. The company also said that they've got a handful of other patients who will probably be infused in next week or two.